OakChart

DocGo Inc

DCGOHealthcare·Medical Care Facilities·USA·Nano·NASD·Nov 11 • 3:59 PM ET

0.2319+0.0065 (2.88%)
2026-11-12 00:10 CET
Market cap
22.31 USD m
Revenue, TTM
297.34 USD m
Net income, TTM
-181.25 USD m
Free cash flow, TTM
-30.36 USD m
EPS diluted, TTM
-1.85
P/E
-
Compare

Price

DCGO against its 20, 50 and 200-day averages
2050200miss
0.200.400.600.801.005.5M10.9MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DCGOclose 0.2320-day 0.2650-day 0.32200-day 0.550.23

79.7% under the 52-week high of 1.15 on 11 Nov 2025. 52-week low 0.21 on 2 Nov 2026. Last 15 sessions, 41.3% high to low

Volume 1.79× normal · the line is the 50-bar volume average

Profile

DCGO
52-week range, 2% of the way up
0.211.14

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Employees3568
IPODec 17, 2020
Beta1.01
ATR, 14d0.03
Rel volume1.79
Short float2.30%
Insider own6.51%
Inst own35.17%

Snapshot

6 groups

Valuation

Index-
Market Cap22.95M
Enterprise Value2.37M
Income-181.25M
Sales297.34M
Book/sh1.06
Cash/sh0.19
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees3568
IPODec 17, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S0.08
P/B0.22
P/C1.20
P/FCF-
EV/EBITDA-
EV/Sales0.01
Quick Ratio1.38
Current Ratio1.38
Debt/Eq0.23
LT Debt/Eq0.15
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.85
EPS next Y-0.27
EPS next Q-0.08
EPS this Y68.37%
EPS next Y53.12%
EPS next 5Y48.25%
EPS past 3/5Y- -49.56%
Sales past 3/5Y-9.90% 27.91%
EPS Y/Y TTM-254.04%
Sales Y/Y TTM-19.22%
EPS Q/Q40.89%
Sales Q/Q3.70%
EarningsNov 09 AMC
EPS/Sales Surpr.-58.14% -4.59%

Ownership

Insider Own6.51%
Insider Trans0.00%
Inst Own35.17%
Inst Trans-8.59%
ROA-68.70%
ROE-96.51%
ROIC-150.60%
Gross Margin27.98%
Oper. Margin-29.04%
Profit Margin-60.96%
SMA20-10.03%
SMA50-27.69%
SMA200-57.62%
Trades-

Technical

Shs Outstand98.99M
Shs Float92.55M
Short Float2.30%
Short Ratio2.63
Short Interest2.13M
52W High1.14 -79.75%
52W Low0.21 11.22%
Volatility13.89% 12.55%
ATR (14)0.03
RSI (14)37.37
Beta1.01
Rel Volume1.79
Avg Volume810.62K
Volume1,447,620

Performance

Perf Week-11.01%
Perf Month-23.99%
Perf Quarter-64.50%
Perf Half Y-60.53%
Perf YTD-73.58%
Perf Year-78.92%
Perf 3Y-95.95%
Perf 5Y-97.31%
Perf 10Y-
Recom2.20
Target Price1.38
Prev Close0.23
Price0.23
Change %2.88%

Analyst ratings

latest 8 of 8
DateActionAnalystRating changeTargetImplied
May 09, 2025DowngradeBBTIG ResearchBuy → Neutral
Feb 28, 2025DowngradeDDeutsche BankBuy → Hold$5 → $2.85+1,129.0%
Aug 18, 2023InitiatedBBTIG ResearchBuy$15+6,368.3%
Apr 21, 2023InitiatedCCantor FitzgeraldOverweight$11+4,643.4%
Apr 19, 2022InitiatedDDeutsche BankBuy$11+4,643.4%
Jan 19, 2022InitiatedSStifelBuy$14+5,937.1%
Dec 21, 2021InitiatedCCanaccord GenuityBuy$13+5,505.9%
Dec 07, 2021InitiatedNNeedhamBuy$14+5,937.1%

Peers

Mkt cap
TickerCompanyMkt cap
SRTAStrata Critical Medical Inc536.82M
ADUSAddus HomeCare Corp2.34B
AVAHAveanna Healthcare Holdings Inc2.86B
JYNTJoint Corp93.09M
AMNAMN Healthcare Services Inc1.46B
BTMDbiote Corp60.74M
PNTGPennant Group Inc1.29B
AMWLAmerican Well Corp211.98M
TDOCTeladoc Health Inc1.63B
LFMDLifeMD Inc85.80M

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Tendler Ely DGeneral Counsel and SecretaryDec 15 '25Sale0.9116,85015,334258,795Dec 16 04:12 PM
Ely D TendlerDirectorDec 15 '25Proposed Sale0.9116,85015,382Dec 15 05:06 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
VHTVanguard Health Care ETFAUM: 21.51B
PRFZInvesco RAFI US 1500 Small-Mid ETFAUM: 2.66B
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.44B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.170-0.108-0.17073.4376.964
2026Q22026-08-17-0.160-0.098-0.16073.4275.354
2026Q12026-05-11-0.150-0.123-0.15075.5572.484
2025Q42026-03-16-1.370-0.142-1.36874.9470.315
2025Q32025-11-10-0.280-0.149-0.28470.8169.796
2025Q22025-08-07-0.110-0.100-0.11380.4277.646
2025Q12025-05-08-0.090-0.032-0.09396.03104.256
2024Q42025-02-27-0.0300.040-0.032120.83129.426
2024Q32024-11-070.0500.0400.052138.68137.846
2024Q22024-08-070.0600.0640.061164.95163.387
2024Q12024-05-080.1000.0810.104192.09187.957
2023Q42024-02-280.0750.1010.073199.25194.217
2023Q32023-11-060.0500.0590.045186.55147.697
2023Q22023-08-07-0.0200.029-0.019125.49119.776
2023Q12023-05-08-0.0300.021-0.034113111.536
2022Q42023-03-130.1100.0710.079108.8104.95

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY0.2450.0340.250318.7294.35
2022FY0.3400.2930.336440.5435.55
2023FY0.0600.1070.065624.2619.24
2024FY0.1800.2530.183616.56625.14
2025FY-1.840-0.670-1.840322.2317.55
2026FY--0.582--299.39
2027FY--0.273--309.09
2028FY--0.255--321.94

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1050576.9874.6778.20
2026Q4S2026-11-0950080.3579.2682.20
2026Q4S2026-11-0650080.3579.2682.20
2026Q4S2026-11-0150080.2879.2682.20
2026Q4S2026-08-1953080.2879.2682.20
2026Q4S2026-08-1853080.1779.2682.20
2026Q4S2026-07-2650079.0377.5281.90
2026Q4S2026-05-1254179.0377.5281.90
2026Q4S2026-05-0751078.0074.7684.50
2026Q4S2026-03-2461178.2874.7684.50
2026Q4S2026-03-2361178.2874.7684.50
2026Q4S2026-03-1761178.3174.7684.50
2026Q4S2026-01-2540076.8974.0082.18
2026Q4S2026-01-1440376.8974.0082.18

Estimate history

EPS, annual-0.2460.250.3360.0650.183-1.841-1.8456
Period202020212022202320242025TTM
EPS, quarterly0.052-0.032-0.093-0.113-0.284-1.368-0.15-0.16-0.168
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual94.091318.719440.516624.289616.555322.196297.34
Period202020212022202320242025TTM
Sales, quarterly138.685120.83396.03380.41870.8174.93675.5573.42573.431
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual76.489100.134102.411104.055101.91198.6498.992
Period202020212022202320242025MRQ
Shares, quarterly101.981101.911100.18497.75797.81198.6498.77898.85898.992
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue297.34322.20616.56624.29440.52318.7294.09
Cost of Goods Sold Incl. D&A214.15239.10418.87445.34296.36216.4868.25
Gross Profit83.1983.10197.69178.95144.16102.2425.84
Selling, General and Administrative Excl. Other169.55172.25169.00163.90120.8686.8840.60
Research and Development14.9513.5611.5910.865.383.321.19
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-86.36-89.1628.6915.0523.3015.36-14.76
Interest Expense0.411.012.17--0.760.20
Unusual Expense81.7695.97-1.05-1.441.87-5.340.00
Net Income Before Taxes-164.44-187.5027.7516.2922.7819.80-14.63
Income Taxes30.898.8714.396.24-7.960.620.17
Consolidated Net Income-195.32-196.3713.3610.0530.7419.18-14.80
Net Income From Continuing Operations-181.25-182.4019.996.8634.5823.74-14.36
Net Income-181.25-182.4019.996.8634.5823.74-14.36
EPS (Recurring)-1.25-1.160.180.060.350.21-0.25
EPS (Basic, Before Extraordinaries)-1.85-1.840.200.070.340.30-0.25
EPS (Diluted)-1.85-1.840.180.060.340.25-0.25
EBITDA-74.44-73.5044.5731.4933.8622.87-9.25
Non-Operating Income (Expense)4.10-1.350.17-0.201.36-0.140.33
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense9.3913.7810.7716.125.681.00-
Price To Earnings Ratio--14.6578.8415.140.34-
Price To Sales Ratio0.130.270.750.951.652.786.30
Gross Margin27.9825.7932.0628.6632.7232.0827.46
Operating Margin-29.04-27.674.652.415.294.82-15.68
Net Margin-60.96-56.613.241.107.857.45-15.26
Shares Outstanding98.9998.64101.91104.06102.41100.1376.49
Market Capitalization22.3122.31432.70580.78726.99935.65145.98

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue73.4373.4275.5574.9470.8180.4296.03120.83
Cost of Goods Sold Incl. D&A51.6153.7154.3154.5256.6558.9868.9583.66
Gross Profit21.8319.7221.2420.4214.1521.4427.0937.18
Selling, General and Administrative Excl. Other39.1137.6439.9552.8639.3938.9241.0844.65
Research and Development4.033.453.713.773.192.963.643.69
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-17.28-17.92-18.71-32.44-25.24-17.48-14.00-7.47
Interest Expense0.060.100.100.150.220.440.430.54
Unusual Expense0.860.002.7678.1417.790.010.04-1.46
Net Income Before Taxes-18.21-17.94-16.68-111.61-43.17-17.92-14.80-6.58
Income Taxes0.080.060.0230.73-13.51-4.63-3.721.07
Consolidated Net Income-18.29-17.99-16.70-142.34-29.66-13.29-11.08-7.65
Net Income From Continuing Operations-16.60-15.82-14.76-134.07-27.77-11.16-9.41-3.26
Net Income-16.60-15.82-14.76-134.07-27.77-11.16-9.41-3.26
EPS (Recurring)-0.16-0.16-0.13-0.81-0.16-0.11-0.09-0.04
EPS (Basic, Before Extraordinaries)-0.17-0.16-0.15-1.37-0.28-0.11-0.09-0.03
EPS (Diluted)-0.17-0.16-0.15-1.37-0.28-0.11-0.09-0.03
EBITDA-14.65-15.23-16.06-28.49-21.27-13.50-10.24-4.15
Non-Operating Income (Expense)-0.000.084.89-0.870.070.01-0.34-0.02
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.262.102.552.484.653.813.823.06
Price To Earnings Ratio------14.3014.65
Price To Sales Ratio0.130.170.210.270.360.360.520.70
Gross Margin29.7226.8528.1127.2519.9926.6628.2130.77
Operating Margin-23.54-24.41-24.77-43.29-35.64-21.74-14.58-6.18
Net Margin-22.61-21.55-19.54-178.91-39.22-13.87-9.79-2.70
Shares Outstanding98.9998.8698.7898.6497.8197.76100.18101.91
Market Capitalization22.3150.9862.1285.86133.02155.59269.24432.70

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments51.0289.2459.29157.34175.5432.42
Short Term Receivables93.38210.90262.08103.0078.3824.85
Inventories0.000.000.000.000.000.00
Other Current Assets8.004.3417.5010.752.111.15
Total Current Assets152.40304.49338.87271.08256.0358.42
Net Property, Plant & Equipment43.5042.1838.4239.3726.2421.10
Total Investments and Advances17.3123.6413.497.374.162.04
Intangible Assets0.0073.1685.2261.8719.3717.28
Deferred Tax Assets7.5618.9811.899.96--
Other Assets3.353.732.573.633.811.32
Total Assets224.12466.18490.45393.28309.60100.17
Short Term Debt Incl. Current Port. of LT Debt10.2138.5531.345.805.424.17
Accounts Payable11.1128.3619.8321.5815.833.95
Other Current Liabilities46.1754.90118.9672.7736.6215.37
Total Current Liabilities67.49121.81170.12100.1657.8823.50
Long Term Debt18.9718.6415.1614.1911.159.73
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities7.0210.56----
Other Liabilities4.780.000.000.0013.520.00
Total Liabilities98.25151.00185.28114.3582.5533.23
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity144.01320.92300.79273.23219.5855.00
Total Shareholders Equity144.01320.92300.79273.23219.5855.00
Accumulated Minority Interest-18.14-5.744.385.707.4811.95
Total Equity125.87315.18305.17278.93227.0666.95
Total Liabilities & Stockholders Equity224.12466.18490.45393.28309.60100.17
Book Value Per Share1.463.152.892.672.190.72
Tangible Book Value Per Share1.462.432.072.062.000.49
Full-Time Employees3,5684,4004,1003,2002,9244
Price to Book Ratio0.211.332.022.754.261.42
Return on Assets-53.674.181.559.8411.16-
Return on Equity-78.466.432.3914.0414.73-
Return on Invested Capital-111.925.892.1712.0310.29-22.19
Quick Ratio2.262.501.992.714.422.49
Current Ratio2.262.501.992.714.422.49

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-195.32-196.3713.3610.0530.7419.18-14.80
Depreciation11.9215.6615.8816.4310.577.075.51
Other Funds (Non Cash)106.67125.7518.1124.4010.690.602.24
Funds from Operations-46.62-47.2150.8248.9042.0526.85-7.05
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital18.6381.6619.29-113.12-13.18-28.80-3.61
Cash from Operating Activities-27.9934.4570.12-64.2228.87-1.95-10.65
Capital Expenditures-5.04-7.43-5.61-10.13-5.50-6.71-6.32
Net Assets From Acquisitions-12.75-16.39-1.85-20.20-32.95-1.300.00
Sale of Fixed Assets and Businesses0.000.200.270.752.070.411.78
Purchase or Sale of Investments1.24-15.46-5.31-0.300.00-0.660.00
Purchase of Investments-17.70-28.62-5.31-0.300.00-0.660.00
Sale Or Maturity of Investments18.9413.160.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.00
Other Sources0.080.000.000.000.000.000.00
Cash from Investing Activities-16.47-39.08-12.50-29.88-36.38-8.26-4.54
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock0.00-10.83-13.731.58-1.75158.290.00
Repurchase of Common Pref Stock0.00-10.83-13.760.00-3.730.000.00
Sale of Common Pref Stock0.000.000.031.581.98158.290.00
Proceedsfrom Stock Options0.000.000.000.000.00157.660.00
Issuance or Reduction of Debt, Net-6.05-35.170.6120.70-3.94-2.82-2.28
Change in Long Term Debt-6.05-5.17-4.39-4.30-3.91-2.82-2.28
Issuance of Long Term Debt0.000.260.000.000.000.000.00
Reduction of Long Term Debt-6.05-5.43-4.39-4.30-3.91-2.82-2.28
Net Financing Active Other Cash Flow-3.04-4.82-9.19-21.17-2.56-0.60-0.03
Other Financing Activities Uses-3.04-4.82-9.19-21.17-2.56-0.60-0.03
Cash from Financing Activities-9.09-50.82-22.311.12-8.24154.87-2.31
Exchange Rate Effect0.260.60-0.191.090.76-0.020.20
Net Change in Cash-53.29-54.8535.12-91.89-15.00144.65-17.31
Free Cash Flow-30.3629.9166.50-71.8125.67-6.81-15.02
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Price to Free Cash Flow-2.916.98-28.36--
Deferred Taxes & Investment Tax Credit-7.753.47-1.98-9.960.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments19.1125.2335.6851.0273.36104.16
Short Term Receivables82.9886.2293.9793.38107.02122.76
Inventories0.000.000.000.000.000.00
Other Current Assets7.628.358.538.009.859.65
Total Current Assets109.71119.80138.17152.40190.23236.57
Net Property, Plant & Equipment36.5238.7342.0143.5043.4544.70
Total Investments and Advances21.5522.8424.2617.3127.2729.97
Intangible Assets1.901.410.640.0059.0376.66
Deferred Tax Assets0.580.560.817.5630.7117.21
Other Assets3.643.483.343.353.093.15
Total Assets173.90186.82209.23224.12353.78408.26
Short Term Debt Incl. Current Port. of LT Debt9.379.6810.1810.219.9340.07
Accounts Payable16.9614.0213.8711.118.0510.12
Other Current Liabilities53.3348.6353.1746.1755.6049.96
Total Current Liabilities79.6672.3377.2267.4973.58100.15
Long Term Debt15.2716.2218.3218.9719.5420.39
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---7.02--
Other Liabilities0.002.482.484.780.000.00
Total Liabilities94.9291.0498.0298.2593.12120.53
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity105.08119.05132.31144.01270.53297.28
Total Shareholders Equity105.08119.05132.31144.01270.53297.28
Accumulated Minority Interest-26.11-23.27-21.10-18.14-9.87-9.55
Total Equity78.9895.78111.21125.87260.66287.73
Total Liabilities & Stockholders Equity173.90186.82209.23224.12353.78408.26
Book Value Per Share1.061.201.341.462.773.04
Tangible Book Value Per Share1.041.191.331.462.162.26
Full-Time Employees---3,568--
Price to Book Ratio0.210.390.430.320.450.51
Return on Assets-68.70-64.67-58.67-53.67-12.17-4.09
Return on Equity-96.51-92.44-85.03-78.46-17.32-5.98
Return on Invested Capital-13.79-11.69-9.80-82.26-9.57-3.51
Quick Ratio1.381.661.792.262.592.36
Current Ratio1.381.661.792.262.592.36

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-18.29-17.99-16.70-142.34-29.66-13.29
Depreciation2.642.692.653.953.973.98
Other Funds (Non Cash)5.283.727.7089.9723.626.02
Funds from Operations-10.33-11.32-6.60-18.37-15.58-8.17
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital6.712.081.957.9017.2441.77
Cash from Operating Activities-3.62-9.24-4.66-10.471.6633.60
Capital Expenditures-0.67-1.15-1.10-2.13-1.56-1.57
Net Assets From Acquisitions0.000.000.00-12.750.000.00
Sale of Fixed Assets and Businesses-0.040.020.020.000.020.08
Purchase or Sale of Investments-0.54-2.752.731.802.64-19.89
Purchase of Investments-6.35-5.75-1.73-3.87-2.52-22.22
Sale Or Maturity of Investments5.813.004.465.685.162.33
Other Uses0.000.000.000.000.000.00
Other Sources0.080.000.000.000.000.00
Cash from Investing Activities-1.18-3.881.66-13.071.10-21.38
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.00-5.08
Repurchase of Common Pref Stock0.000.000.000.000.00-5.08
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-1.63-1.57-1.42-1.43-31.02-1.41
Change in Long Term Debt-1.63-1.57-1.42-1.43-1.02-1.41
Issuance of Long Term Debt0.000.000.000.000.260.00
Reduction of Long Term Debt-1.63-1.57-1.42-1.43-1.28-1.41
Net Financing Active Other Cash Flow-1.47-0.09-1.05-0.43-2.03-0.89
Other Financing Activities Uses-1.47-0.09-1.05-0.43-2.03-0.89
Cash from Financing Activities-3.10-1.66-2.46-1.86-33.05-7.38
Exchange Rate Effect0.050.14-0.210.28-0.650.65
Net Change in Cash-7.85-14.64-5.67-25.12-30.955.50
Free Cash Flow-3.74-9.56-5.09-11.960.7832.90
Price to Free Cash Flow--3.732.882.471.86

Revenue breakdown

United Kingdom2024: 57.76M 2025: 53.94M
United States2024: 558.79M 2025: 268.25M
Mobile Health Services2024: 423.13M 2025: 121.43M
Transportation Services2024: 193.43M 2025: 200.77M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.30%2.1M92.6M738.70K
2026-10-152.14%2.0M92.6M728.13K
2026-09-302.15%2.0M92.5M741.97K
2026-09-152.99%2.8M92.5M943.51K
2026-08-312.52%2.3M92.5M942.39K
2026-08-142.40%2.2M92.5M764.34K
2026-07-312.64%2.4M92.3M789.32K
2026-07-152.50%2.3M92.3M880.38K
2026-06-302.65%2.4M92.3M1.03M
2026-06-154.94%4.6M92.3M968.56K
2026-05-295.13%4.7M92.3M995.90K
2026-05-155.07%4.7M92.3M995.79K
2026-04-305.26%4.9M92.3M1.05M
2026-04-157.42%6.4M86.2M1.04M
2026-03-316.37%5.5M86.2M886.71K
2026-03-136.85%5.9M86.2M734.40K
2026-02-276.81%5.8M85.4M712.89K
2026-02-136.91%5.9M85.4M749.79K
2026-01-307.15%5.8M80.8M815.93K
2026-01-157.21%5.8M80.8M1.84M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.000.450.050.00045.000.000.0000.0000.000
call1.000.000.350.0527.4529320.000.963-0.0040.000
call1.500.000.850.0028.3910.000.000.963-0.0050.000
call2.000.000.850.0029.0300.000.000.962-0.0050.000
call3.000.000.850.0029.8960.000.000.962-0.0050.000
call4.000.000.850.0530.4891.000.000.962-0.0050.000
put0.500.050.650.300.00017.000.000.0000.0000.000
put1.000.301.000.800.00030.000.00-0.037-0.0040.000
put1.500.801.551.300.00058.000.00-0.037-0.0050.000
put2.001.302.001.800.00026.000.00-0.038-0.0050.000
put3.002.303.002.800.00038.000.00-0.038-0.0050.000
put4.003.304.003.800.0008.000.00-0.038-0.0050.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-10-058-KCurrent report2026-10-01SEC
2026-08-1710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-178-KCurrent report2026-08-16SEC
2026-08-10NT 10-Q2026-06-30SEC
2026-07-318-KCurrent report2026-07-28SEC
2026-07-28SCHEDULE 13G/ASEC
2026-07-028-KCurrent report2026-06-26SEC
2026-06-188-KCurrent report2026-06-16SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-118-KCurrent report2026-05-11SEC
2026-05-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-228-KCurrent report2026-04-17SEC
2026-04-22ARSAnnual report to security holders. 2025-12-31SEC
2026-04-22DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-22DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-16SEC
2026-04-10PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-04-10SEC
2026-03-314Statement of changes in beneficial ownership of securities2026-03-30SEC
2026-03-26SCHEDULE 13G/ASEC
2026-03-17S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-03-168-KCurrent report2026-03-16SEC
2026-03-1610-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-26SCHEDULE 13D/ASEC
2026-01-308-KCurrent report2026-01-26SEC
2025-12-164Statement of changes in beneficial ownership of securities2025-12-12SEC
2025-12-164Statement of changes in beneficial ownership of securities2025-12-12SEC
2025-12-164Statement of changes in beneficial ownership of securities2025-12-12SEC
2025-12-164Statement of changes in beneficial ownership of securities2025-12-12SEC
2025-12-164Statement of changes in beneficial ownership of securities2025-12-12SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120015.33K1
2025-110000

Institutional holders

Manager% owned
P.A.W. CAPITAL CORP3.80%
VANGUARD CAPITAL MANAGEMENT LLC3.77%
Knott David M Jr2.70%
Peapod Lane Capital LLC2.53%
CITADEL ADVISORS LLC2.38%
RENAISSANCE TECHNOLOGIES LLC2.28%
S SQUARED TECHNOLOGY, LLC2.08%
ACADIAN ASSET MANAGEMENT LLC1.76%
AQR CAPITAL MANAGEMENT LLC1.73%
MOORE CAPITAL MANAGEMENT, LP1.48%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.70%
VANGUARD EXTENDED MARKET INDEX FUND0.97%
Fidelity Small Cap Index Fund0.90%
Fidelity Extended Market Index Fund0.51%
VANGUARD RUSSELL 2000 INDEX FUND0.46%
Schwab U.S. Small-Cap ETF0.44%
Putnam Small Cap Value Fund0.36%
VANGUARD HEALTH CARE INDEX FUND0.27%
Franklin U.S. Small Cap Equity Fund0.24%
Schwab Small-Cap Index Fund0.19%

OakChart. DCGO. Cached 15 minutes.